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Early endosomes represent the first sorting station
for vesicular ubiquitylated cargo. Tollip, through its
C2domain, associateswith endosomal phosphatidy-
linositol 3-phosphate (PtdIns(3)P) andbindsubiquity-
lated cargo in these compartments via itsC2 andCUE
domains. Tom1, through its GAT domain, is recruited
to endosomes by binding to the Tollip Tom1-binding
domain (TBD) through an unknown mechanism. Nu-
clear magnetic resonance data revealed that Tollip
TBD is a natively unfolded domain that partially folds
at its N terminus when bound to Tom1 GAT through
high-affinity hydrophobic contacts. Furthermore,
this association abrogates binding of Tollip to
PtdIns(3)P by additionally targeting its C2 domain.
Tom1 GAT is also able to bind ubiquitin and
PtdIns(3)P at overlapping sites, albeit withmodest af-
finity. We propose that association with Tom1 favors
the release of Tollip from endosomal membranes, al-
lowing Tollip to commit to cargo trafficking.
INTRODUCTION
In higher eukaryotes, protein internalization, lipid membranes,
and extracellular fluid are taken from a diverse array of endocytic
pathways through processes that involve recruitment of endo-
cytic proteins aswell as changes in plasmamembrane curvature.
Themechanism of protein internalization (cargo) includes ubiqui-
tylation and endocytosis, followedby cargo delivery into early en-
dosomes (Platta andStenmark, 2011).Cargo is further sorted into
the intralumenal vesicles of late endosomes or multivesicular
bodies (MVBs) for later degradation in the lysosomal lumen.
Some cargo, however, is recycled back to the plasmamembrane
for additional rounds of ligand binding and further internalization.
The endosomal signaling output strictly depends on the pres-
ence of adaptor proteins as well as the endosomal lipid mem-1910 Structure 23, 1910–1920, October 6, 2015 ª2015 Elsevier Ltd Abrane composition, which is predominantly enriched with
phosphatidylinositol 3-phosphate (PtdIns(3)P) at the cytosolic
face (Gillooly et al., 2000). A number of peripheral cytosolic pro-
teins are recruited to endosomal membranes by recognition of
PtdIns(3)P through their phosphoinositide-binding modules,
which exhibit a modest affinity for the lipid. This property allows
for their rapid and reversible binding mode, a mechanism that
depends not only on PtdIns(3)P levels but also on the presence
of pre-localized binding partners (Cullen, 2008). Ubiquitylation
of cargo serves as a sorting signal for delivery from the plasma
membrane to the early endosomes. As such, cargo is recognized
by adaptor proteins, which work coordinately to generate unique
sorting membrane domains. For example, the hepatocyte
growth factor-regulated tyrosine kinase substrate (Hrs) is an
FYVE domain-containing protein that binds PtdIns(3)P, favoring
Hrs endosomal recruitment. Interestingly, Hrs weakly binds the
ubiquitin moiety of cargo, thus requiring the presence of addi-
tional ubiquitin-binding proteins to make the endosomal sorting
complex required for transport (ESCRT) (Jovic et al., 2010).
ESCRT proteins, such as Hrs, are required for sorting ubiquity-
lated cargo into intralumenal vesicles and for intralumenal
vesicle formation (Haglund and Dikic, 2012).
Tollip is an adaptor protein involved in protein sorting through
association with Tom1, ubiquitin, and clathrin (Yamakami et al.,
2003). Tollip is mainly localized on early endosomes, where it is
required for both degradation of ubiquitin-conjugated proteins
(Katoh et al., 2004) and sorting of interleukin-1 receptor (IL-1R)
at late endosomes (Brissoni et al., 2006). Also, Tollip serves
as a negative modulator of Toll-like receptor (TLR) signaling
pathways by sequestration of interleukin receptor-associated ki-
nases (IRAKs) (reviewed in Capelluto, 2012), and directly medi-
ates polyQ protein removal through the autophagy pathway (Lu
et al., 2014). This versatile function of Tollip is associated with
its modular nature; it contains the Tom1-binding domain (TBD),
C2, and CUE domains. Whereas the C2 domain of Tollip prefer-
entially binds PtdIns(3)P and PtdIns(4,5)P2 (Ankem et al., 2011),
which allows for the protein’s membrane targeting, both the C2
and CUE domains bind ubiquitin in a mechanism that impairs
phosphoinositide binding (Mitra et al., 2013).ll rights reserved
Figure 1. Tollip TBD Is Intrinsically Disor-
dered and Partially Folds upon Binding to
the Tom1 GAT Domain
(A) Schematic representations of the Tollip and
Tom1 domain boundaries and their ligand part-
ners. Tollip residues F21 and K162, relevant for
Tom1 GAT and PtdIns(3)P interactions, respec-
tively, are labeled. The Tom1 N230 residue, critical
for Tollip TBD binding, is also labeled.
(B) HSQC spectrum and resonance assignments
of 15N-Tollip TBD. Inset: Far-UV CD spectrum of
Tollip TBD. Red bar indicates the dispersion of the
NMR resonances.
(C) HSQC spectrum and resonance assignments
of 15N-Tollip TBD in the presence of Tom1 GAT.
(D) Chemical-shift perturbations of Tollip TBD
upon Tom1 GAT domain binding. The colored
dashed lines represent significant chemical-shift
changes: red (Ddaverage +1.5 3 SD) > orange
(Ddaverage +13 SD) > yellow (Ddaverage). Secondary
structural content of Tollip TBD is displayed at the
top of the histogram.
See also Figures S1 and S8.The subfamily of Tom1, Tom1L1, and Tom1L2 adaptor pro-
teins presents an N-terminal VHS domain followed by a GAT
domain. The GAT domain is a three-helix bundle module that in-
teracts with both ubiquitin and the TBD region of Tollip (Katoh
et al., 2004; Yamakami et al., 2003). Structural studies of the
Tom1 GAT-ubiquitin complex suggest the presence of two po-
tential ubiquitin-binding sites in the GAT domain (Akutsu et al.,
2005). Tom1 interacts with clathrin, thus emphasizing its role in
membrane trafficking (Yamakami et al., 2003), and exhibits a
negative regulatory role by promoting lysosomal degradation of
IL-1R, an event that requires Tollip (Brissoni et al., 2006). Amodel
hasbeenproposed inwhich IL-1R is shuttled fromTollip toTom1,
which in turn promotes the recruitment of the endosomal degra-
dation machinery (Brissoni et al., 2006). Thus, Tollip- and Tom1-
mediated cargo trafficking seem to act parallel to, or instead of,
the ESCRT-0 complex, which also recognizes cargo during the
initial step of endosomal sorting (Shields and Piper, 2011).
To unveil the regulatory mechanism underlying Tollip-Tom1
complex formation, we first structurally characterized Tollip
TBD association with the Tom1 GAT domain. This high-affinity
association triggered drastic conformational changes in both
protein domains, most notably by Tom1 GAT-induced Tollip
TBD folding at its N terminus. We further demonstrated that
the association of Tom1 with Tollip inhibits binding of Tollip to
PtdIns(3)P, a mechanism that may facilitate Tollip’s commitment
to Tom1-mediated endosomal cargo trafficking.
RESULTS
Tollip TBD Is Intrinsically Disordered and Partially Folds
upon Tom1 GAT Domain Binding
It was previously shown that Tollip TBD is required for binding to
Tom1 via its GAT domain (Katoh et al., 2004; Yamakami et al.,
2003) (Figure 1A). The 1H-15N heteronuclear single-quantumStructure 23, 1910–coherence (HSQC) spectrum of Tollip TBD was characteristic
of an unstructured protein as indicated by the narrow dispersion
in the 1HN dimension (Figure 1B). Likewise, the far-UV circular di-
chroism (CD) spectrum of Tollip TBD displayed a minimum at
200 nm, a feature of unstructured protein spectra (Figure 1B,
inset). Nonetheless, identification of the nuclear magnetic reso-
nances (NMRs) of Tollip TBD was almost complete (94%; resi-
dues Val5, Gln29, and Gln30 were not assigned). Titration of
the unlabeled Tom1 GAT domain into the 15N-labeled Tollip
TBD resulted in dramatic improvement in resonance dispersion
(Figure 1C). Resonance perturbations clustered in the first half
of Tollip TBD including two N-terminal b strands. The largest
chemical-shift perturbations were observed in residues Arg9,
Val12, Ile14, Asp20, and Arg23 (Figure 1D). Interestingly, the
GAT domain-perturbed region in TBD represents the most
conserved among Tollip proteins (Figure S1A). The effect of the
Tom1 GAT domain was specific, since the Tollip TBD HSQC
spectrum was not perturbed by ubiquitin (Figure S1C), a ligand
of the Tollip C2 and CUE domains (Mitra et al., 2013), nor by
PtdIns(3)P (Figure S1D), a ligand of the C2 (Ankem et al., 2011)
and GAT domains (see Figures S6B and S6D) (Boal et al., 2015).
Tom1 GAT Also Undergoes Structural Conformational
Changes upon Binding to Tollip TBD
We expanded the NMR experiments to define the binding site
of Tollip TBD in Tom1 GAT. The HSQC spectrum of the Tom1
GAT domain displayed scattered resonances, of which 96%
were identified (residues Glu215, Ala276, Asn277, and Glu278
were not assigned) (Figure 2A). Direct comparison of the
HSQC spectra of the Tollip TBD-free and Tollip TBD-bound
Tom1 GAT domain revealed a drastic change in the position of
the Tom1 GAT resonances (Figures 2A and 2B), suggesting
that binding is accompanied by a conformational change in
the protein. Most of the chemical-shift perturbations were1920, October 6, 2015 ª2015 Elsevier Ltd All rights reserved 1911
Figure 2. Identification of the Tollip TBD-Interacting Residues in
Tom1 GAT
(A and B) HSQC spectra and resonance assignments of 15N-Tom1 GAT in the
absence (A) and presence (B) of Tollip TBD.
(C) Normalized chemical-shift perturbations in the backbone amides of Tom1
GAT induced by Tollip TBD. The colored dashed lines represent significant
chemical-shift changes as described in the legend of Figure 1. Secondary
structure of the Tom1 GAT domain is depicted at the top.
See also Figures S1, S3, and S8.mapped in the a1 and a2 helices of the Tom1 GAT domain,
with the largest perturbations observed in residues Lys219,
Leu220, Leu257, Arg267, Val268, and Ile275 (Figures 2C and
S1B).1912 Structure 23, 1910–1920, October 6, 2015 ª2015 Elsevier Ltd AIntermolecular nuclear Overhauser effects (NOEs) between
the Tollip TBD and Tom1 GAT domains were acquired from
half-filtered NOE spectroscopy (NOESY)-HSQC experiments.
Many intermolecular NOEs were detected, and the most evident
included Tollip TBD Leu17 with Tom1 GAT Ala263 and Met264
(located in helix a2), Tollip TBD Gln19 with Tom1 GAT Thr260
and Cys261 (helix a2), and Tollip TBD Phe21 with Tom1 GAT
Glu223, Leu224, Glu225, Met226, and Val227 (helix a1), and
Met264 (helix a2). Of note, the Tollip TBD Gln19 backbone reso-
nance could not be assigned in the Tom1 GAT-bound state. The
Tollip TBD Leu17 backbone resonance was perturbed by Tom1
GAT (Figure 1C), but the Tom1 GAT-induced conformational
change of Tollip TBD could mask the significance of the amino
acid in Tom1 GAT binding from chemical-shift data analysis.
Thus, the NOE data suggest that many of the Tom1 GAT- and
Tollip TBD-mediated resonance perturbations in Tollip TBD
and Tom1 GAT, respectively (Figures 1C and 1D, and 2B and
2C), are a consequence of conformational changes in the
proteins.
The Tom1 GAT-Bound Tollip TBD Structure Reveals N-
Terminal Folding
To gain structural insights into the Tollip-Tom1 complex, we
sought to solve the solution structure of Tollip TBD in the Tom1
GAT-bound state. Initial structural analysis of Tom1 GAT-bound
Tollip TBD rendered a TBD structure with residues Ala2-Ser6
and Pro11-Ile14 adopting a single anti-parallel b sheet, whereas
residues Ala37-Tyr45 formed a short C-terminal helical element
that capped the b-sheet element of the protein (data not shown).
However, the presence of a well-definedC-terminal helix in Tollip
TBD was not in agreement with TalosN (Shen and Bax, 2013)
analysis based on chemical shifts (data not shown). We therefore
measured the internal backbone motions of Tom1 GAT-bound
Tollip TBD by analysis of the 1H-15N heteronuclear NOEs and
the 15N relaxation times. The 1H-15N NOE profile showed that
the first 22 residues of Tollip TBD were highly ordered, whereas
the C-terminal half of the protein was disordered (Figure S2A).
Considerable internal motion at the C terminus of Tom1 GAT
domain-bound Tollip TBD was also observed when the T1 and
T2 relaxation times as well as R1*R2 were estimated (Figures
S2B–S2D). Together, these data suggest that the conserved
N-terminal Tollip TBD becomes ordered upon Tom1 GAT bind-
ing, whereas its C-terminal region remains relatively disordered.
We speculate that the presence of a putative helix in the initial
structure can represent a transient structural element in Tollip
TBD. We therefore generated the Tom1 GAT-bound structure
of Tollip TBD (residues 1–22), which still exhibited an anti-parallel
b-sheet at the N terminus (Figure 3A and Table 1). Thus, the
Tom1 GAT-induced chemical-shift perturbations in Tollip TBD
could be mapped onto its structure (Figure 3B). The structure
of the Tollip TBD-bound state Tom1 GAT domain (Figure 3C
and Table 1) displayed a three-helix bundle, consistent with
that reported in the ubiquitin-bound state (Akutsu et al., 2005),
but the a3 helix was four residues shorter in the Tollip TBD-
bound state. Residues of the Tom1 GAT domain, whose reso-
nances were perturbed by Tollip TBD, were clustered on the
Tom1 GAT domain structure (Figure 3D). Given the limited num-
ber of identified intermolecular NOEs (Table 1), we were unable
to confidently dock Tollip TBD onto the Tom1 GAT domainll rights reserved
Figure 3. AnalysisofTollipTBDandTom1GATStructureandFunction
(A) Ensemble of the 20 lowest-energy structures of Tollip TBD (residues 1–22)
in the Tom1 GAT-bound state (left) and stereo image of its structure (right) as
determined by NMR. Residue side chains, which form NOEs with Tom1 GAT,
are shown in pink.
(B) Two views of Tollip TBD labeled with the residues whose resonances were
perturbed by the presence of the Tom1 GAT domain. The color code is as
indicated in the legend of Figure 1. Tollip F21 also showed intermolecular
NOEs with Tom1 GAT (asterisk).
(C) Ensemble of the 20 lowest-energy structures of Tom1 GAT in the Tollip
TBD-bound state (left) and stereo image of its structure (right) as determined
by NMR.
(D) Two views of the Tom1 GAT domain structure mapping residues whose
chemical shifts were induced by Tollip TBD binding. Color code is as indicated
in the legend of Figure 1. Residues marked by a star also showed intermo-
lecular NOEs with Tollip TBD.
See also Figures S1 and S2.
Structure 23, 1910–structure. Nonetheless, based on Tollip TBD structural confor-
mation and NOE data, the Tom1 GAT-binding site in Tollip
TBD displays a loop with three conserved interacting residues,
Leu17, Gln19, and Phe21, which form a relatively hydrophobic-
groove pocket that contacts the Tom1 GAT a1 and a2 helices,
which are also mostly hydrophobic.
Identification of Critical Residues Involved in Tollip TBD-
Tom1 GAT Association
NMR data indicated that Tollip TBD bound tightly to the Tom1
GAT domain in a slow exchange regime, since subequimolar
concentrations of Tollip TBD showed two states for most of
the Tom1 GAT resonances, whereas an excess of the unlabeled
partner did not induce further changes in Tom1 GAT spectra
(Figure S3). We therefore determined the affinity between
Tom1 GAT and Tollip TBD using surface plasmon resonance
(SPR) titrations. Tollip TBD bound immobilized Tom1 GAT with
high association and low dissociation rates, and with an esti-
mated dissociation constant (KD) of 0.67 nM (Table 2 and Fig-
ure S4A). Additional domains in the full-length proteins may
contribute to the binding, such as the Tollip C2 domain (i.e., Fig-
ure S7B), as reflected by the 8-fold increment in the conforma-
tion-associated equilibrium constant Kconf (data not shown)
that results in a 3-fold increment in affinity (Table 2 and Fig-
ure S4B). We sought to provide additional information by intro-
ducing individual mutations on surface-exposed and conserved
interacting residues (Figure S1). Site-directed mutagenesis of
Tollip TBD-interacting residues of Tom1 GAT such as Glu223,
Val227, and Asn230 (helix a1) and Leu257, Met264, and
Arg267 (helix a2) reduced their interaction with Tollip TBD (Table
2 and Figures S4C–S4H) but did not affect protein folding, as
judged by comparison with the wild-type Tom1 GAT domain
spectrum using CD spectroscopy (data not shown). Mutations
on other residues presumably involved in Tollip TBD binding,
such as Met226 (helix a1) and Cys261 (helix a2), did not drasti-
cally affect Tollip TBD binding (Table 2 and Figures S4I–S4J),
indicating that these residues do not contribute to complex for-
mation in a critical manner. Alanine mutations in Tollip TBD Arg9/
Val12 and Asp20/Arg23 reduced Tom1GAT binding (Table 2 and
Figures S4K–S4L). Notably, mutation in Phe21, a conserved res-
idue in Tollip (Figure S1A) that forms several intermolecular
NOEs, and its NH backbone resonance is shifted when bound
to the Tom1 GAT domain, reducing binding affinity by
20,000-fold (Table 2 and Figure S4M). Consequently, the affin-
ity of Tom1 GAT N230A for Tollip TBD F21A showed 60,000-
fold reduction in the equilibrium constant Kb (data not shown)
leading to 95,000-fold reduction in binding (Table 2 and Fig-
ure S4N), suggesting that these residues reduce the affinity in
the initial binding event, and consequently are critical for
Tom1-Tollip complex formation.
To explore the consequences of disrupting Tom1-Tollip asso-
ciation in a more physiological setting, we introduced mutations
in the GAT and TBD regions to evaluate whether disruption of
their interaction influences subcellular localization of the pro-
teins. As previously reported, Tollip localizes in early endo-
somes, cytosol, and, presumably, in late endosomes (Brissoni
et al., 2006; Katoh et al., 2004), and Tom1 is cytosolic unless
co-expressed with Tollip, in which Tom1 predominantly co-lo-
calizes with Tollip (Katoh et al., 2004) (Figures 4A–4C).1920, October 6, 2015 ª2015 Elsevier Ltd All rights reserved 1913
Table 1. NMR and Refinement Statistics for Tollip TBD Bound to
the Tom1 GAT Domain and for Tom1 GAT Bound to Tollip TBD
Tollip TBD
(Tom1 GAT
Bound)
Tom1 GAT
(Tollip TBD
Bound)
NMR Distance and Dihedral Constraints
Distance restraints
Total 134
Intraresidue 33
Interresidue 101
Sequential (ji  jj = 1) 40
Medium-range (ji  jj <
5)
19
Long-range (ji  jjR 5) 42
Intermolecular 12
Hydrogen bonds 0
Dihedral angle restraints
Total 10 164
F 5 82
J 5 82
Structure Statistics
Violations >0.5 A˚ (mean ±
SD)
14.8 ± 1.7
Distance constraints (A˚) 0.19 ± 0.01
Dihedral angle constraints
()
14 ± 43 0.26 ± 1.7
Max. dihedral angle
violation ()
65 ± 68 15.7 ± 7.9
Max. distance constraint
violation (A˚)
3.00 ± 0.24
Deviations from idealized geometry
Bond lengths (A˚) 0.008 0.012
Bond angles () 0.5 0.7
Average pairwise rmsd (A˚)a,b
Protein
Heavy 1.7 1.1
Backbone 2.4 1.5
See also Figure S2.
aPairwise backbone and heavy-atom root-mean-square deviations
(rmsd) were obtained by superimposing residues 1–22 of Tollip TBD
among the 20 lowest-energy refined structures.
bPairwise backbone and heavy-atom rmsd were obtained by superim-
posing residues 215–309 of Tom1 GAT among the 20 lowest-energy
refined structures.
Table 2. Dissociation Constants (KD) of the Protein-Ligand
Complexes Described in This Study
Protein KD (nM) Fit (c
2) Fold
Tom1 GAT-Tollip TBD 0.67 ± 0.02 0.05 1
Tom1 GAT E223A-Tollip TBD 40.80 ± 0.55 0.20 61
Tom1 GAT M226A-Tollip TBD 3.84 ± 0.07 0.04 6
Tom1 GAT V227A-Tollip TBD 21.30 ± 0.88 0.07 32
Tom1 GAT N230A-Tollip TBD 459.40 ± 7.55 0.05 685
Tom1 GAT L257A-Tollip TBD 221.00 ± 45.94 0.08 330
Tom1 GAT C261S-Tollip TBD 3.10 ± 0.18 0.04 5
Tom1 GAT M264A-Tollip TBD 45.20 ± 4.88 0.04 68
Tom1 GAT R267A-Tollip TBD 25.70 ± 1.03 0.09 38
Tom1 GAT-Tollip TBD R9A/V12A 55.70 ± 0.82 0.06 83
Tom1 GAT-Tollip TBD D20A/R23A 82.10 ± 4.39 0.07 123
Tom1 GAT-Tollip TBD F21A 14,500 ± 2,192 8.26 20,000
Tom 1 GAT N230A-Tollip
TBD F21A
63,500 ± 282 2.53 95,000
Tom1-Tollip 0.23 ± 0.07 0.72 0.3
Tom1 GAT-Ubiquitin 12,000 ± 4,114 0.64 18,000
Tom1 GAT-PtdIns(3)P 18,150 ± 2,100 0.34 27,000
See also Figure S4. Values are the averages of three independent mea-
surements.Furthermore, subcellular localization of Tollip partially overlaps
with the early endosomal antigen 1 (EEA1), consistent with
spatial restriction of protein complexes on endosomal mem-
brane domains, which enable unique signaling responses (Platta
and Stenmark, 2011). Co-transfection of Tollip with Tom1 N230A
led to an increase in cytosolic localization and reduction of vesic-
ular localization of Tom1N230Awithout changing the subcellular
punctate pattern of Tollip (Figure S5A). Tollip F21A exhibited a
subcellular distribution similar to that of the wild-type protein
(Figure 4D), but unexpectedly showed a more diffused subcellu-1914 Structure 23, 1910–1920, October 6, 2015 ª2015 Elsevier Ltd Alar localization when co-expressed with Tom1 (albeit they
displayed overlapping distribution) (Figure S5B). Cellular co-
expression of Tollip F21A and Tom1 N230A display a similar
outcome, with a significant loss of punctate localization of Tollip
F21A (Figure 4E). We speculate that this result is a consequence
of Tom1 association with the Tollip C2 domain (see next section).
The PtdIns(3)P-binding deficient mutant Tollip K162A (Ankem
et al., 2011) shows a punctate pattern but did not merge with
EEA1 (Figure S5C), suggesting that Tollip K162A is being
excluded from endosomal PtdIns(3)P-enriched domains and
that binding to ubiquitylated cargo likely provides for endosomal
localization of the protein. Moreover, this mutant retains the abil-
ity to recruit Tom1 (Figure S5D), indicating that the association of
Tom1 with Tollip is independent of Tollip’s PtdIns(3)P binding.
Tom1 Inhibits Binding of Tollip to PtdIns(3)P
Tollip is likely recruited to early endosomal compartments by as-
sociation with membrane-embedded PtdIns(3)P (Brissoni et al.,
2006). By using a lipid-protein overlay assay, Tollip, but not
Tom1, bound PtdIns(3)P (Figures 5A and S6A). Using the same
assay, but with 3-fold higher protein concentration, Tronchere
and colleagues recently reported that the Tom1 GAT domain
bindsmonophosphate phosphoinositides, although the associa-
tion seems to lack specificity (Boal et al., 2015). To shed light on
these conflicting data, we further explored lipid association of
the Tom1 GAT domain using more highly sensitive methods
such as NMR spectroscopy. Stepwise addition of PtdIns(3)P
induced minor perturbations in specific resonances of the
Tom1 GAT domain following a fast-exchange regime (Fig-
ure S6B). Perturbations occurred mainly at the first half of helix
a1 and the C-terminal half of helix a2, and minor perturbations
were found in helix a3, suggesting that the PtdIns(3)P-binding
site overlaps with that of Tollip TBD (Figure S6C and S6D). Thell rights reserved
Figure 4. Deficient Tollip- and Tom1-Bind-
ingMutants Impair Tom1Recruitment to En-
dosomal Compartments
(A–C) HeLa cells were transiently transfected with
plasmids expressing EGFP-Tollip (A), FLAG-Tom1
(B), or both (C), and proteins were detected using
immunofluorescence analysis. Endogenous EEA1
was employed as an early endosomal marker.
(D and E) HeLa cells were transfected with con-
structs expressing EGFP-Tollip F21A (D) or co-
expressing EGFP-Tollip F21A and FLAG-Tom1
N230A (E), and proteins were detected using
immunofluorescence analysis
Scale bar, 10 mm. See also Figure S5.apparent KD of the Tom1 GAT domain for PtdIns(3)P, measured
by SPR, was estimated to be 18 mM (Table 2 and Figure S4O).
As Tom1 GAT binds Tollip TBD with an affinity that is 27,000-
fold stronger than that of PtdIns(3)P, it is unlikely that PtdIns(3)P
can displace Tollip TBD for binding to the Tom1 GAT domain.
Next, we investigated the functional role of Tom1 association
with Tollip at the endosomal compartments. Pre-incubation of
Tollip with Tom1 abolished Tollip’s PtdIns(3)P in a concentra-
tion-dependent manner (Figure 5A). PtdIns(3)P inhibition wasStructure 23, 1910–1920, October 6, 2015specific for Tollip, since binding to the
phosphoinositide by the Vam7p PX
domain remained unchanged in the pres-
ence of Tom1 (Figure S6E). Furthermore,
Tollip F21A also bound PtdIns(3)P, and
pre-incubation of this mutant with Tom1
N230A did not affect lipid binding (Fig-
ure 5A). Thus, the data indicate that the
interaction of Tom1 GAT with Tollip TBD
is required to block the binding of Tollip
to PtdIns(3)P.
Since Tollip binding to PtdIns(3)P is
mediated by its C2 domain (Ankem
et al., 2011), we asked whether the
Tom1 GAT domain can directly bind to
the Tollip C2 domain. Whereas no reso-
nance perturbations were observed
when Tollip TBD was titrated with the
Tollip C2 domain in the absence of the
Tom1 GAT domain (Figure S7A), the
Tom1 GAT domain directly contacted
the Tollip C2 domain, even in the
absence of Tollip TBD (Figures 5C, S7B,
and S7C), with high affinity (KD of
187 nM; Table 2 and Figure S4P). Inter-
estingly, Tollip C2-mediated perturba-
tions mainly occurred at the a3 helix of
the Tom1 GAT domain (Figure 5C), which
leaves the possibility of Tollip TBD bind-
ing at the a1 and a2 helices (Figure 2C).
Binding of Tom1 (or its GAT domain)
showed minor effects on the binding of
the Tollip C2 domain to PtdIns(3)P (Fig-
ure S7D), suggesting that Tollip TBD
plays a major role in the inhibition. Wethen examined whether the Tom1 GAT domain can simulta-
neously bind the TBD and C2 domains. We titrated a pre-
formed 15N-labeled Tollip TBD-Tom1 GAT complex with Tollip
C2 domain using HSQC analysis. Addition of the Tollip C2
domain led to evident line broadening, perturbations, and split-
ting of some Tollip TBD resonances (Figure 5D), suggesting that
a TBD-GAT-C2 complex is formed. Notably, some of the Tollip
C2 domain-induced resonance perturbations of the Tom1 GAT-
bound Tollip TBD complex were also observed in Tom1 GATª2015 Elsevier Ltd All rights reserved 1915
Figure 5. Tom1 Inhibits Binding of Tollip to
PtdIns(3)P
(A) Lipid-protein overlay assay of the indicated
proteins with immobilized PtdIns(3)P. GST-Tollip
was pre-incubated in the absence and presence
of His-Tom1 at the indicated molar ratios for 1 hr
at room temperature. GST was employed as a
negative control.
(B) Inhibition of binding of Tollip to PtdIns(3)P was
simultaneously judged by pre-incubation of an
excess of either His-Tom1 or its His-GAT domain.
(C) Histogram plot of resonance perturbations for
15N-Tom1 GAT as a function of residue number.
The significance of the perturbations is color
coded and the procedure is as indicated in
Figure 1.
(D) Expansions of 1H-15N HSQC spectra regions
showing residue resonances of 15N-labeled Tollip
TBD-Tom1 GAT (1:1.2) in the absence (red) and
presence (black) of a 2-fold excess of Tollip C2
domain. The contour level of the Tollip TBD spec-
trum was increased 2-fold to visualize its reso-
nances in the presence of the Tollip C2 domain.
See also Figures S6, S7, and S8.domain-bound Tollip TBD spectra (Figure 2A). Overall, the data
indicate that association of Tom1 with Tollip is mediated by
contacts with both the TBD and C2 domains in Tollip by its
GAT domain, thus inhibiting the association of Tollip with endo-
somal PtdIns(3)P.
Lastly, we analyzed the role of ubiquitin in Tollip TBD-Tom1
GAT complex formation. Ubiquitin binds the Tom1 and GGA3
GAT domains at two potential sites, known as 1 and 2, with
site 2 being the dominant ubiquitin-binding site (Akutsu et al.,
2005; Bilodeau et al., 2004). Addition of ubiquitin into the 15N-
labeled Tom1 GAT domain-induced perturbations over all the
protein residue resonances, but the most pronounced effects
were on the residues of helix 3 (Figures S8A and S8B), where
site 2 is located, with an estimated KD of 12 mM (Table 2 and
Figure S4Q). Ubiquitin-induced Tom1 GAT resonance perturba-
tions overlapped with those induced by the Tollip C2 domain
(Figure 5C), but excluded the Tollip TBD-binding site (Figure 3C).
Moreover, the drastic resonance perturbations induced by Tollip
TBD (Figure 2B) suggested that Tom1 GAT might adopt a
different conformational state, which could preclude ubiquitin
binding. These observations raise the conflicting question of
whether the Tom1GAT domain is able to bind Tollip and ubiquitin
simultaneously (Katoh et al., 2004; Yamakami et al., 2003).
Analytical ultracentrifugation analysis showed that Tom1 GAT
formed a tight complex with Tollip TBD (Figures S8C and S8E).1916 Structure 23, 1910–1920, October 6, 2015 ª2015 Elsevier Ltd All rights reservedNo ternary complex composed of Tollip
TBD, Tom1 GAT, and ubiquitin could
be detected (Figures S8F–S8H). Taken
together, our data indicate that Tom1,
via its GAT domain, can associate with
either Tollip (through its TBD andC2mod-
ules) or ubiquitin. As Tollip TBD and C2
bind Tom1 GAT 18,000- and 60-fold
stronger than ubiquitin, respectively(Table 2), the ubiquitin-binding function of Tom1 GAT is likely
abrogated by Tollip binding.
DISCUSSION
In the present study, we determined the solution NMR structures
of the Tollip TBD and Tom1 GAT domains in their bound states
and showed that association of Tom1 with Tollip inhibits Tollip’s
PtdIns(3)P binding. Tollip TBD is intrinsically disordered and un-
dergoes a partial folding-upon-binding switch in the presence of
the Tom1 GAT domain. The flexible nature of Tollip TBD allows
for an unusually high-affinity hydrophobic interaction with the
Tom1 GAT domain. Intriguingly, we demonstrated that the
Tom1 GAT domain, in addition to ubiquitin and PtdIns(3)P, also
binds to the Tollip C2 domain. Despite the fact that Tom1 GAT
associates with the Tollip C2 domain with high affinity, Tollip
TBD is required to interact with Tom1 GAT to abolish the binding
of Tollip to the phosphoinositide. On the basis of these observa-
tions, we propose a mechanism for Tollip’s regulation and
commitment to endosomal cargo trafficking (Figure 6), given
that Tollip also negatively modulates IRAK-1 (Burns et al.,
2000), TLR2, TLR4, and IL-1R (Zhang and Ghosh, 2002)
activities.
Endosomal PtdIns(3)P facilitates recruitment of adaptor pro-
teins, which stereospecifically recognize the phosphoinositide
Figure 6. Proposed Mechanism for the Role
of Tom1 Association with Tollip at the Sur-
face of Early Endosomes
(A) Tollip is in equilibrium between the cytosolic
and endosomal compartments. Tollip associates
with endosomal membranes through association
with PtdIns(3)P via its C2 domain.
(B) Ubiquitylated cargo is delivered to early endo-
somal membranes through vesicular transport.
The Tollip CUE domain associates with ubiquity-
lated cargo, whereas the C2 domain remains
bound to the phosphoinositide due to its higher
affinity for the lipid.
(C) The Tom1 GAT domain binds to the Tollip TBD
and C2 domains. These interactions impair binding
of Tollip to PtdIns(3)P, thus increasing Tollip’s
commitment for binding to ubiquitylated cargo.
These associations promote stabilization of
Tollip at endosomal compartments favoring cargo
clustering.through their domains (Bissig and Gruenberg, 2013). PtdIns(3)P
modestly contributes to the release of the intralumenal vesicle
(Wollert et al., 2009), thus placing the lipid with more relevance
to protein recruitment at the endosomal surface. Other factors,
such as membrane charge and curvature, also contribute to
the targeting of PtdIns(3)P effectors to endosomal compart-
ments (Schink et al., 2013). We propose that Tollip exists in equi-
librium between cytosolic and endosomal compartments, in
which PtdIns(3)P provides the platform for recruitment of Tollip.
Tom1 binding to Tollip triggers Tollip release from PtdIns(3)P and
increases the commitment of Tollip for binding to ubiquitylated
cargo, which is anchored on the same membrane domains (Fig-
ure 6). The effect of Tom1 is plausible, since its affinity for Tollip is
very high and, consequently, can compete efficiently with
PtdIns(3)P for Tollip binding. The disordered nature of TBD facil-
itates Tollip’s hydrophobic interaction with helices 1 and 2 of the
Tom1GAT domain, whereas Tollip’s C2 domain likely associates
with the third helix of Tom1 GAT. Furthermore, this mechanism
could be enhanced by the presence of ubiquitin-conjugated
cargo, since Tom1 may bind simultaneously to ubiquitin via its
VHS domain (Ren and Hurley, 2010), while remaining associated
with Tollip. We observed that the cytosolic accumulation of
Tom1, as a consequence of its inability to bind to Tollip, pro-
motes cytosolic accumulation of Tollip. Likewise, cytosolic
localization of endosomal Endofin was observed when a
Tom1-binding defective mutant of Endofin was co-expressed
with Tom1 (Seet et al., 2004), suggesting that accumulation of
cytosolic Tom1 influences subcellular localization of Endofin.
Given that Tom1 also binds to the Tollip C2 domain, it is plausible
that, in the absence of a functional TBD, Tollip is relocated
cytosolically in a Tom1-dependent manner. For example, Tollip
negatively modulates innate immunity responses through cyto-
solic interactions with IL-1R and IRAKs, which are TBD indepen-
dent (Burns et al., 2000).
Intrinsically disordered proteins (IDPs) present charged and
polar residues and sequence repeats, and lack a hydrophobic
core at high frequency, which favors their unfolded state (For-
man-Kay and Mittag, 2013). In addition, the less abundant large
hydrophobic residues of IDPs are usually engaged in the recog-
nition of binding partners, and their ability to trigger enthalpicallyStructure 23, 1910–favorable reactions supports high-affinity interactions (Forman-
Kay and Mittag, 2013). All these features are found in Tollip
TBD, which is unusually rich in glutamine residues and exhibits
conserved Qf repeats. Indeed, two conserved hydrophobic res-
idues, L17 and F21, directly contact the Tom1 GAT domain.
Since IDPs are able to interact with different partners due to their
ability to adopt distinct conformations, it is plausible that Tollip
exhibits such an array of binding partners through interactions
with its TBD that are yet to be established. It is also noteworthy
that three Tollip truncated isoforms have been reported, two of
which show deletions in their TBDs (reviewed in Capelluto,
2012). This is of evolutionary importance because driver muta-
tions in human diseases are observed more frequently in disor-
dered rather than folded protein domains, as mutations in folded
domains may disrupt structure and, therefore, function in these
proteins (Forman-Kay and Mittag, 2013).
Tom1 has recently been reported to weakly bind phosphatidy-
linositol monophosphates (Boal et al., 2015) and does so under
conditions whereby Shigella flexneri inositol phosphate phos-
phatase increases endosomal levels of PtdIns(5)P (Ramel
et al., 2011). The lipid-binding function of Tom1 is particularly
relevant in higher plants, since neither Tollip nor ESCRT-0 pro-
teins are encoded by these organisms (Blanc et al., 2009; Schell-
mann and Pimpl, 2009). The plant Tom1 homolog has recently
been demonstrated to bind phospholipids (Blanc et al., 2009),
and these associations localize Tom1 to early endosomes (Kor-
bei et al., 2013). Since mammalian Tom1 shares common inter-
acting partners with ESCRT-0, it is likely that Tom1 participates
in cargo transport. Tom1 co-immunoprecipitates with Hrs,
suggesting that they form protein complexes together (Brissoni
et al., 2006) in endosomal compartments (Katoh et al., 2004).
ESCRT-0 is able to recruit at least eight ubiquitin molecules
simultaneously (Mayers and Audhya, 2012). Tom1 is able to
bind at least three ubiquitin molecules, two by its GAT domain
(Akutsu et al., 2005) and one by its VHS domain (Ren and Hurley,
2010), although these multiple interactions likely occur in the
absence of Tollip. In addition, Tollip binds to ubiquitin through
its C2 and CUE domains (Mitra et al., 2013; Shih et al., 2003)
and forms oligomers (Yamakami et al., 2003). Given that
ESCRT-0, Tollip, and Tom1 bind ubiquitin with modest affinity,1920, October 6, 2015 ª2015 Elsevier Ltd All rights reserved 1917
simultaneous binding to multiple ubiquitin molecules may in-
crease their avidity for cargo interactions (Schink et al., 2013).
Overall, the Tom1-Tollip complex formation function is in line
with what has been proposed for ESCRT-0, which is able to clus-
ter cargo to efficiently sort them for their degradation (Mayers
and Audhya, 2012).
This study uncovers the negativemodulation of Tom1 on Tollip
PtdIns(3)P binding. Moreover, our data demonstrate that the as-
sociation of Tollip with Tom1 follows a folding-upon-binding
mechanism in TBD. The Tom1-Tollip complex is favored by addi-
tional contacts between their GAT and C2 domains. The pres-
ence of additional components of the Tollip-Tom1 complex
and crosstalk of these proteins with members of the ESCRT
family represent areas of future investigation to enable under-
standing of how adaptor proteins coordinately work to mediate
endosomal cargo delivery.
EXPERIMENTAL PROCEDURES
Cloning, Expression, and Purification
Human Tom1, Tom1GAT (residues 215–309), and Tollip TBD cDNAs (residues
1–53) were expressed as both glutathione S-transferase (GST) and His-tagged
fusion proteins, human Tollip and Tollip C2 (residues 54–182) were expressed
as GST-fusion proteins, and ubiquitin was expressed as a His-tagged fusion
protein. For details, see Supplemental Experimental Procedures.
NMR Titrations and Structure Determination
NMR experiments were performed at 25C on a Bruker 600-MHz spectrom-
eter equipped with a TBI probe (Virginia Tech), and with cold probe-equipped
Bruker 800-MHz (University of Virginia) and Varian 900-MHz (University of
Colorado at Boulder) spectrometers. 1H chemical shifts were referenced using
sodium 4,4-dimethyl-4-silapentane-1-sulfonate (50 mM), whereas 15N and 13C
chemical shifts were referenced indirectly using frequency ratios as described
by Wishart et al. (1995). Proteins for structure determination were prepared
from 13C,15N-labeled Tollip TBD with unlabeled Tom1 GAT or 13C,15N-labeled
Tom1 GAT with unlabeled Tollip TBD in 20 mM d11-Tris-HCl (pH 7.0), 50 mM
KCl, 1 mM d18-DTT, and 1 mM NaN3. Labeled protein concentration ranged
between 0.8 and 1mM, and themolecular ratio between labeled and unlabeled
protein was 1:1.2. Backbone and side-chain resonances were assigned using
HNCO, HNCACO, HNCACB, CBCACONH, NOESY-HSQC, and total correla-
tion spectroscopy-HSQC experiments. Intramolecular and intermolecular
NOEs were obtained by 13C,15N-edited and 13C,15N-filtered NOESY-HSQC,
respectively. The NOEs identified in the complex include Tollip TBD Leu17
HD1-Tom1 GAT Ala263 HN; Tollip TBD Leu17 HD2-Tom1 GAT Ala263 HN;
Tollip TBD Leu17 HD1-Tom1 GAT Met264; HN Tollip TBD Leu17 HD2-Tom1
GAT Met264 HN; Tollip TBD Gln19 HG-Tom1 GAT Thr260 HN; Tollip TBD
Gln19 HG-Tom1 GAT Cys261 HN; Tollip TBD Phe21 HN-Tom1 GAT Glu223
HN; Tollip TBD Phe21 HN-Tom1 GAT Leu224 HN; Tollip TBD Phe21 HN-
Tom1 GAT Glu225 HN; Tollip TBD Phe21 HN-Tom1 GAT Met226 HN; Tollip
TBD Phe21 HN-Tom1 GAT Val227 HN; and Tollip TBD Phe21 HN-Tom1 GAT
Met264 HN. 1H-15N HSQC experiments were used to track protein interactions
using 15N-labeled proteins at concentrations of 70–100 mM. Spectra were pro-
cessed with Topspin and NMRPipe (Delaglio et al., 1995), and analyzed by
Sparky (Goddar and Kneller, 2008). The chemical-shift perturbations were
calculated using the following equation (Gautier et al., 2010):
Dd(1H,15N) = [(Dd1H)2 + (Dd15N)2/6]0.5.
Individual structures of GAT and TBD were generated using resolution-
adapted structural recombination (RASREC) Rosetta. Rosetta parameters
were selected using the CS-Rosetta Toolkit (http://csrosetta.chemistry.ucsc.
edu), with Rosetta 3.5 (http://www.rosettacommons.org) compiled with MPI
support. For Tom1 GAT, chemical-shift information was used to guide the
structure calculation in both the fragment selection and the RASREC stages.
For Tollip TBD (residues 1–22), a combination of chemical shifts and NOEs
were used to obtain a converged structure, with the distance constraints
included in the latter stages of RASREC optimization. Rosetta calculations uti-1918 Structure 23, 1910–1920, October 6, 2015 ª2015 Elsevier Ltd Alized the Janus Supercomputer (UC Boulder), which consists of 1,368 com-
puter nodes, each with two six-core 2.8-GHz Intel Westmere CPUs, 24 Gb
RAM, and an 800-TB Luster file system. Calculations were run across 44
nodes, totaling 528 CPUs. The Rosetta calculations yielded 500 RASREC
selected structures of Tollip TBD. From these, 20 structures were selected
based on their score and root-mean-square deviations, and converted to
PDB format. NMR structural statistics for the 20 lowest-energy conformers
of Tollip TBD and Tom1 GAT were obtained using the Protein Structure Valida-
tion Suite. Using MolProbity, the Ramachandran analysis of the 20 superim-
posed lowest-energy Tollip TBD structures (in a Tom1 GAT-bound state)
identified that 97.1% of the residues are in the most favored regions and
2.9% in the allowed regions, with no Ramachandran outliers. In the case of
Tom1 GAT (Tollip TBD-bound state), the analysis showed that 99.9% of the
residues are in the most favored regions, 0.1% in the allowed regions, and
0% in disallowed regions. The structures of the Tom1 GAT-bound Tollip
TBD and the Tollip TBD-bound Tom1 GAT have been deposited in the PDB
(http://www.rcsb.org) under accession codes PDB: 2n31 and 2n2n, respec-
tively. Related entries have been deposited in the BMRB under accession co-
des BMRB: 26573 (Tollip TBD), 26574 (Tom1 GAT), 25632 (Tom1 GAT-bound
Tollip TBD), and 25602 (Tollip TBD-bound Tom1 GAT). Longitudinal (R1) and
transverse (R2)
15N relaxation rates and 1H-15N NOEs (Cavanagh et al.,
2007) were measured at 25C using a Bruker Avance III 600-MHz spectrom-
eter. Standard Bruker pulse sequences were used. Recycle delays of 2 s
were used during R1 and R2 measurements. Relaxation delays for R1 experi-
ments were 5, 50, 150, 250, 400, 550, 750, 1,200, and 2,000 ms. Relaxation
delays for R2 experiments were 17, 34, 68, 85, 119, 153, and 204 ms.
1H-15N NOEs were measured by comparing intensities of 1H-15N correlation
spectra with either 5 s of 1H saturation or a 5-s delay preceding 1H-15N corre-
lation. NMRPipe (Delaglio et al., 1995) was used for spectral processing and
visualization, and measurement of peak intensities and spin relaxation rates.
SPR Kinetic Studies
SPR measurements were performed at room temperature using a BIAcore
X-100 instrument (GE Healthcare). Protein-protein interaction experiments
were performed in 10 mM HEPES (pH 7.4), 150 mM NaCl, 50 mM EDTA, and
0.005% P20 (running buffer). A purified His-tagged protein (ligand) (2–10 nM)
was immobilized on a nitrilotriacetic acid (NTA) sensor chip (15–110
response units) according to the manufacturer’s instructions. The NTA chip
was saturated with 0.5 mM NiCl2 in each cycle, then the protein analyte was
diluted into the running buffer at different concentrations and injected over
both ligand and reference flow cells at a flow rate of 30 ml/min. The signal
from the experimental flow cell was corrected by subtraction from the refer-
ence flow cell. The chip was regenerated with 10 mM HEPES (pH 8.3),
150 mM NaCl, 3 mM EDTA, and 0.005% P20 before the next cycle. Associa-
tion of Tom1 GAT to PtdIns(3)P-containing liposomes was monitored using an
L1 sensor chip, similar to what we have previously described (Ankem et al.,
2011). Apparent KD values were calculated using the BIAevaluation software,
version 2.0 (GE Healthcare) and, in all cases, data best fit the two-state confor-
mational change model. In this model, an initial binding event takes place,
which is measured by the equilibrium association constant Kb (Kb = ka1/kd1).
Furthermore, the protein(s) undergoes a reversible conformational change in
the bound state, which is calculated by the equilibrium constant Kconf (Kconf =
ka2/kd2 and Ka = Kb(1 + Kconf) = 1/KD) (De Mol and Fisher, 2008).
Cell Cultures and Immunofluorescence Analysis
HeLa cells (American Type Culture Collection) were grown in Dulbecco’s min-
imal essential medium supplemented with 10% (v/v) heat-inactivated fetal
BSA (Sigma) in a 37C humidified incubator in the presence of 5% CO2. Cells
were split every 2–3 days and maintained at 50% confluence. Transient trans-
fection of Tom1 (in pCS2+-FLAG) and Tollip (in pEGFPc1) plasmids was per-
formed using Lipofectamine LTX (Invitrogen) using 1 mg of DNA and 2.2 ml of
Lipofectamine in OptiMEM reduced serum medium (Invitrogen) for 106 cells.
Cells grown on grid-glass coverslips were fixed and permeabilized in 3.7%
formaldehyde, 0.1% Triton X-100, and PBS for 7 min at room temperature,
and blocked with 20%goat serum in 0.1%Triton X-100 and PBS. Primary anti-
body (mouse anti-FLAG M2 [Sigma] or mouse anti-EEA1 [BD Transduction
Laboratories] antibodies) was added to cells and incubated at 4C overnight
followed by incubation with Cy3-conjugated goat anti-mouse antibodyll rights reserved
(Affinipurer) for 1 hr at room temperature. Coverslips were mounted onto glass
slides with Elvanol mounting medium. Images were analyzed with a Nikon
Eclipse TE2000-E microscope equipped with a Prairie sweptfield confocal
system and analyzed using the NIS-Elements AR 4.2 software (Nikon).
Lipid-Protein Overlay Assay
PtdIns(3)P strips were prepared by spotting 1 ml of the indicated amount of
PtdIns(3)P dissolved in chloroform/methanol/water (65:35:8) onto Hybond-C
extra membranes (GE Healthcare). PtdIns(3)P membrane strips were blocked
with 3% fatty acid-free BSA (Sigma) in 20 mM Tris-HCl (pH 8.0), 150 mMNaCl,
and 0.1% Tween 20 for 1 hr at room temperature. In some cases, GST-fusion
proteins were pre-incubated with the indicated excess molar ratios of His-
Tom1 or His-Tom1 GAT for 1 hr at room temperature. Then membranes
were incubated with proteins in the same buffer overnight at 4C. Following
four washes with the same buffer, bound proteins were detected with rabbit
anti-GST antibody (Santa Cruz Biotechnology) and donkey anti-rabbit horse-
radish peroxidase antibody (GE Healthcare). Protein binding was probed using
Supersignal West Pico chemiluminescent reagent (Pierce).
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